Tech Company Financing Transactions
Nuritas Funding Round
Nuritas, based in Cambridge, secured $3.2 million from New Protein Capital and private investors.
Transaction Overview
Company Name
Announced On
10/27/2015
Transaction Type
Venture Equity
Amount
$3,200,000
Round
Undisclosed
Investors
New Protein Capital (Lead Investor) (Matthieu Vermersch)
Proceeds Purpose
With this investment we will become even better at speedily unlocking nature's life-changing secrets that have remained hidden until now and as a result, improve global health.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy. 14th floor CIC Cambridge
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
Nuritas was founded by Dr. Nora Khaldi, a mathematician with a PhD in Molecular Evolution and Bioinformatics to revolutionize the discovery of novel, natural and scientifically proven active ingredients that promote and manage our health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nora Khaldi
Chief Operating Officer
Brendan Smyth
VP - Bus. Development
Timothy Considine
VP - Customer Service
Andrew Cassidy
VP - Customer Service
Neil Foster
VP - Manufacturing
Mark Gaffney
Browse more venture capital transactions:
Prev: 10/27/2015: Stuk venture capital transaction
Next: 10/27/2015: SourceClear venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs